These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 8105618)

  • 1. alpha-Amino-n-butyric acid methyl ester induces concentrative uptake of L-dopa in human Langerhans' cells normally not operative for L-dopa transport.
    Falck B; Andersson L; Mikulowska A; Ronquist G
    Acta Derm Venereol; 1993 Jun; 73(3):197-9. PubMed ID: 8105618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mediated exodus of L-dopa from human epidermal Langerhans cells.
    Falck B; Bendsoe N; Ronquist G
    Amino Acids; 2004 Mar; 26(2):133-8. PubMed ID: 15042441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of a new amino acid transport system in human epidermal Langerhans cells: the L-dopa influx/efflux cycle.
    Bendsöe N
    Ups J Med Sci; 2003; 108(3):161-92. PubMed ID: 15000456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functionally different Langerhans' cells in human epidermis.
    Warfvinge K; Mikulowska A; Falck B
    Acta Derm Venereol; 1991; 71(5):429-30. PubMed ID: 1684473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New mechanism for amino acid influx into human epidermal Langerhans cells: L-dopa/proton counter-transport system.
    Falck B; Bendsoe N; Ronquist G
    Exp Dermatol; 2003 Oct; 12(5):602-9. PubMed ID: 14705800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of the L-dopa transport system in human epidermal Langerhans cells by omeprazole and its analogues.
    Bendsoe N; Ronquist G
    Amino Acids; 2004 Feb; 26(1):19-26. PubMed ID: 14752612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro uptake of L-dopa and catecholamines into the epidermal Langerhans cell.
    Axelsson S; Elofsson R; Falck B; Sjöborg S
    Acta Derm Venereol Suppl (Stockh); 1978; 58(79):31-5. PubMed ID: 278443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apical and basolateral 4F2hc and the amino acid exchange of L-DOPA in renal LLC-PK1 cells.
    Soares-da-Silva P; Serrão MP
    Amino Acids; 2005 Nov; 29(3):213-9. PubMed ID: 16136276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High- and low-affinity transport of L-leucine and L-DOPA by the hetero amino acid exchangers LAT1 and LAT2 in LLC-PK1 renal cells.
    Soares-da-Silva P; Serrão MP
    Am J Physiol Renal Physiol; 2004 Aug; 287(2):F252-61. PubMed ID: 15271688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of L-DOPA transport in cultured rat and mouse astrocytes.
    Tsai MJ; Lee EH
    J Neurosci Res; 1996 Feb; 43(4):490-5. PubMed ID: 8699535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The molecular mechanism of intestinal levodopa absorption and its possible implications for the treatment of Parkinson's disease.
    Camargo SM; Vuille-dit-Bille RN; Mariotta L; Ramadan T; Huggel K; Singer D; Götze O; Verrey F
    J Pharmacol Exp Ther; 2014 Oct; 351(1):114-23. PubMed ID: 25073474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and evaluation of radioiodinated 6-iodo-L-DOPA as a cerebral L-amino acid transport marker.
    Kawai K; Ohta H; Kubodera A; Channing MA; Eckelman WC
    Nucl Med Biol; 1996 Apr; 23(3):251-5. PubMed ID: 8782233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. L-DOPA (L-3,4-dihydroxyphenylalanine) uptake by human red blood cells.
    Floud A; Fahn S
    Biochim Biophys Acta; 1981 Jul; 645(2):165-9. PubMed ID: 7272286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The dopamine precursor L-dihydroxyphenylalanine is transported by the amino acid transporters rBAT and LAT2 in renal cortex.
    Quiñones H; Collazo R; Moe OW
    Am J Physiol Renal Physiol; 2004 Jul; 287(1):F74-80. PubMed ID: 15180924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cloning and gene silencing of LAT2, the L-3,4-dihydroxyphenylalanine (L-DOPA) transporter, in pig renal LLC-PK1 epithelial cells.
    Soares-Da-Silva P; Serrão MP; Pinho MJ; Bonifácio MJ
    FASEB J; 2004 Oct; 18(13):1489-98. PubMed ID: 15466357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of apical transporter of L-DOPA in human intestinal Caco-2 cells.
    Fraga S; Sampaio-Maia B; Serrão MP; Soares-da-Silva P
    Acta Physiol Scand; 2002 Jun; 175(2):103-11. PubMed ID: 12028130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison between the L-DOPA histofluorescence procedure and the indirect immunofluorescence with anti-T6 and -HLA-DR monoclonal antibodies in visualizing Langerhans cells of human epidermis.
    Crivellato E; Damiani D; Mallardi F
    Acta Histochem; 1990; 88(1):59-64. PubMed ID: 2113342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular modulation of inward and outward apical transporters of L-dopa in LLC-PK(1) cells.
    Soares-Da-Silva P; Serrão MP
    Am J Physiol Renal Physiol; 2000 Oct; 279(4):F736-46. PubMed ID: 10997924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Na+-independent transporters, LAT-2 and b0,+, exchange L-DOPA with neutral and basic amino acids in two clonal renal cell lines.
    Gomes P; Soares-da-Silva P
    J Membr Biol; 2002 Mar; 186(2):63-80. PubMed ID: 11944084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous boluses and continuous infusions of L-dopa methyl ester in fluctuating patients with Parkinson's disease.
    Stocchi F; Ruggieri S; Carta A; Ryatt J; Quinn N; Jenner P; Marsden CD; Agnoli A
    Mov Disord; 1992; 7(3):249-56. PubMed ID: 1620143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.